1/253/3477937475 |
您所在的位置:网站首页 › 1/253/3477937475 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/31387598Serum CCL20 combined with IL-17A as early diagnostic and …网页2019年8月6日 · Dan Wang # 1 2 , Weitang Yuan # 3 , Yaping Wang # 1 , Qian Wu 1 2 , Li Yang 1 2 , Feng Li 1 2 , Xinfeng Chen 1 2 , Zhen Zhang 1 2 , Weina Yu 1 2 , Nomathamsanqa Resegofetse Maimela 1 2 , Ling Cao 1 2 , Dong Wang 1 2 , Junxia Wang 4 , Zhenqiang Sun 3 , Jinbo Liu 3 , Yi Zhang 5 6 7 8
发布时间:2024-07-11data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/30274984Targeting Resistance against the MDM2 Inhibitor RG7388 in ... - PubMed网页2019年1月1日 · Purpose: Resistance is an obstacle of glioma therapy. Despite targeted interventions, tumors harbor primary resistance or become resistant over short course of treatment. This study examined the mouse double minute 2 (MDM2) inhibitor RG7388 together with radiotherapy and analyzed strategies to overcome acquired MDM2 inhibitor …
发布时间:2024-07-11data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/11134220Increasing volume and changing characteristics of invasive ... - PubMed网页2001 Jan 1;19(1):253-9. doi: 10.1200/JCO.2001.19.1.253. Authors D Caillot 1 , J F Couaillier, A Bernard, O Casasnovas, D W ... Affiliation 1 Department of Clinical Hematology, University Hospital of Dijon, Dijon, France. [email protected]; PMID: 11134220 DOI: 10.1200/JCO.2001.19.1.253 Abstract Purpose: In patients with neutropenia ...
发布时间:2024-07-11CopyRight 2018-2019 实验室设备网 版权所有 |